Diagnosis and treatment of neuromyelitis optica: Consensus recommendations of the Neuromyelitis Optica Study Group;Diagnostik und therapie der neuromyelitis optica: Konsensusempfehlungen der neuromyelitis optica studiengruppe

Nervenarzt

Volumn 82, Issue 6, 2011, Pages 768-777

  Trebst, C ^a   Berthele, A ^b   Jarius, S ^c   Kumpfel T ^d   Schippling, S ^e,y   Wildemann, B ^c   Wilke, C ^f,z   Aktas, O ^g   Brettschneider, J ^h   Faiss, J ⁱ   Gass, A ^j   Geis, C ^k   Hemmer, B ^b   Hoffmann, F ^l   Hofstadt van Oy, U ^m   Japp, G ⁿ   Kern, P ⁱ   Kleinschnitz, C ^k   Kleiter, I ^o   Kohler W ^p   Krumbholz, M ^d   Linker, R ^q   Marziniak, M ^r   Melms, A ^s   Metz, I ^t   Neuhaus, O ^u   Paul, F ^v   Reuss, R ^w   Ringelstein, M ^g   Rommer, S P ^x   Ruprecht, K ^v   Stangel, M ^a   Tumani, H ^h   Winkelmann, A ^x   Zettl, U ^x   Ziemann, U ^aa   more..

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f HELIOS Vorgtland Klinikum   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY OF ULM   (Germany)

ⁱ Asklepios Klinik Teupitz   (Germany)

^j UNIVERSITY OF BASEL   (Switzerland)

^k UNIVERSITY OF WÜRZBURG   (Germany)

^l Krankenhaus Martha Maria Halle   (Germany)

^m INSTITUTE OF PATHOLOGY   (Germany)

ⁿ OOP Privatärztliches Zentrum Frankfurt   (Germany)

^o UNIVERSITY OF REGENSBURG   (Germany)

^p Fachkrankenhaus Hubertusburg   (Germany)

^q RUHR UNIVERSITY BOCHUM   (Germany)

^r UNIVERSITY OF MÜNSTER   (Germany)

^s UNIVERSITY OF TÜBINGEN   (Germany)

^t UNIVERSITY OF GÖTTINGEN   (Germany)

^u Kreiskrankenhaus Sigmaringen   (Germany)

^v CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^w Bezirkskrankenhaus Bayreuth   (Germany)

^x UNIVERSITY OF ROSTOCK   (Germany)

^y UNIVERSITY OF HAMBURG   (Germany)

^z Childrens Hospital   (Germany)

^aa GOETHE UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CONSENSUS; DIAGNOSTIC PROCEDURE; MYELOOPTIC NEUROPATHY; REVIEW; TREATMENT INDICATION;

EID: 79959876661     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-010-3192-4     Document Type: Review

References (86)

1. Aktas O, Hartung HP (2009) Neuromyelitis and more: the unfolding spectrum of aquaporin 4-related neurological diseases. J Neurol 256:1906-1908
2. Bakker J, Metz L (2004) Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG). Can J Neurol Sci 31:265-267 (Pubitemid 38724824)
3. Balcer LJ (2006) Clinical practice. Optic neuritis. N Engl J Med 354:1273-1280
4. Barbieri F, Buscaino GA (1989) Neuromyelitis optica in the elderly. Acta Neurol 11:247-251
5. Barkhof F, Filippi M, Miller DH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059-2069 (Pubitemid 27493740)
6. Bergamaschi R (2003) Glatiramer acetate treatment in Devic's neuromyelitis optica. Brain 126:1E-a
7. Bergamaschi R, Jarius S, Robotti M et al (2009) Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol 256:2097-2099
8. Bergamaschi R, Tonietti S, Franciotta D et al (2004) Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler 10:2-4 (Pubitemid 38100519)
9. Bergamaschi R, Uggetti C, Tonietti S et al (2003) A case of relapsing neuromyelitis optica treated with glatiramer acetate. J Neurol 250:359-361 (Pubitemid 36399281)
10. Bizzoco E, Lolli F, Repice AM et al (2009) Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 256:1891-1898
11. Bonnet F, Mercie P, Morlat P et al (1999) Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus 8:244-247 (Pubitemid 29186845)
12. Cree BA, Lamb S, Morgan K et al (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270-1272
13. Davis R, Thiele E, Barnes P, Riviello JJ Jr (1996) Neuromyelitis optica in childhood: case report with sequential MRI findings. J Child Neurol 11:164-167 (Pubitemid 26098144)
14. Seze J de, Stojkovic T, Ferriby D et al (2002) Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57-61 (Pubitemid 34462145)
15. Filippi M, Rocca MA (2004) MR imaging of Devic's neuromyelitis optica. Neurol Sci 25(Suppl 4):371-373
16. Gartzen K, Limmroth V, Putzki N (2007) Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. Eur J Neurol 14:12-13
17. Ghezzi A, Bergamaschi R, Martinelli V et al (2004) Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol 251:47-52 (Pubitemid 38210489)
18. Gold R, Hartung HP, Hohlfeld R et al (2009) Therapie der Multiplen Sklerose mit monoklonalen Antikörpern. Ergebnisse und Empfehlungen einer Arbeitstagung des Ärztlichen Beirats der Deutschen Multiple Sklerose Gesellschaft. Akt Neurol 36:334-344
19. Hayakawa S, Mori M, Okuta A et al (2008) Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 196:181-187
20. Herrmann W, Obeid R (2008) Ursachen und frühzeitige Diagnostik von Vitamin-B12-Mangel. Dtsch Arztebl 105:680-685
21. Jacob A, Matiello M, Weinshenker BG et al (2009) Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol 66:1128-1133
22. Jacob A, Weinshenker BG (2008) An approach to the diagnosis of acute transverse myelitis. Semin Neurol 28:105-120 (Pubitemid 351273088)
23. Jacob A, Weinshenker BG, Violich I et al (2008) Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 65:1443-1448
24. Jarius S, Aboul-Enein F, Waters P et al (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131:3072-3080
25. Jarius S, Franciotta D, Bergamaschi R et al (2008) Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry 79:1134-1136
26. Jarius S, Franciotta D, Bergamaschi R et al (2010) Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin Chem Lab Med 48:659-663
27. Jarius S, Franciotta D, Bergamaschi R et al (2007) NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68:1076-1077 (Pubitemid 46569147)
28. Jarius S, Franciotta D, Paul F et al (2010) Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 7:52
29. Jarius S, Frederikson J, Waters P et al (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298:158-162
30. Jarius S, Jacob S, Waters P et al (2008) Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4. J Neurol Neurosurg Psychiatry 79:1084
31. Jarius S, Paul F, Franciotta D et al (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202-214 (Pubitemid 351516748)
32. Jarius S, Probst C, Borowski K et al (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 291:52-56
33. Jarius S, Wildemann B (2007) Neuromyelitis optica. Nervenarzt 78:1365-1377 (Pubitemid 350196836)
34. Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6:383-392
35. Kalluri SR, Illes Z, Srivastava R et al (2010) Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Arch Neurol 67:1201-1208
36. Kay CS, Scola RH, Lorenzoni PJ et al (2008) NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci 275:148-150
37. Kidd D, Burton B, Plant GT, Graham EM (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126:276-284 (Pubitemid 36172735)
38. Kim W, Min SP, Sang HL et al (2010) Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 16:1229-1236
39. Klawiter EC, Alvarez E III, Xu J et al (2009) NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology 72:1101-1103
40. Krampla W, Aboul-Enein F, Jecel J et al (2009) Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol 19:2535-2543
41. Lee DH, Metz I, Berthele A et al (2010) Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology. Neuropathol Appl Neurobiol (Epub ahead of print)
42. Lennon VA, Kryzer TJ, Pittock SJ et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473-477 (Pubitemid 41186945)
43. Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112 (Pubitemid 39626806)
44. Lim BC, Hwang H, Kim KJ et al (2010) Relapsing demyelinating CNS disease in a Korean pediatric population: multiple sclerosis versus neuromyelitis optica. Mult Scler (Epub ahead of print)
45. Llufriu S, Castillo J, Blanco Y et al (2009) Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months. Neurology 73:949-953
46. Lotze TE, Northrop JL, Hutton GJ et al (2008) Spectrum of pediatric neuromyelitis optica. Pediatrics 122:1039-1047
47. Lucchinetti CF, Mandler RN, McGavern D et al (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125:1450-1461 (Pubitemid 34755161)
48. Mader S, Lutterotti A, Di Pauli F et al (2010) Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS One 5:e10455
49. Mandler RN, Ahmed W, Dencoff JE (1998) Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51:1219-1220 (Pubitemid 28473439)
50. Mandler RN, Davis LE, Jeffery DR, Kornfeld M (1993) Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34:162-168 (Pubitemid 23223043)
51. Matiello M, Lennon VA, Jacob A et al (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70:2197-2200
52. McKeon A, Lennon VA, Jacob A et al (2009) Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39:87-90
53. Minagar A, Sheremara W (2000) Treatment of Devic's disease with methotrexate and prednisone. Int J MS Care 2:39-43
54. Miyamoto K, Kusunoki S (2009) Intermittent plasmapheresis prevents recurrence in neuromyelitis optica. Ther Apher Dial 13:505-508
55. Mok CC, To CH, Mak A, Poon WL (2008) Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica. J Rheumatol 35:172-174
56. Nakamura M, Misu T, Fujihara K et al (2009) Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 15:695-700
57. O'Riordan JI, Gallagher HL, Thompson AJ et al (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382-387 (Pubitemid 26118744)
58. Okada K, Tsuji S, Tanaka K (2007) Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica. Intern Med 46:1671-1672 (Pubitemid 350111162)
59. Papeix C, Vidal JS, Seze J de et al (2007) Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13:256-259 (Pubitemid 46592781)
60. Paty DW, Oger JJ, Kastrukoff LF et al (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180-185 (Pubitemid 18036832)
61. Paul F, Jarius S, Aktas O et al (2007) Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 4:e133
62. Paul F, Jarius S, Glumm R et al (2008) Recent findings in pathogenesis, diagnostics and therapy of neuromyelitis optica. Dtsch Med Wochenschr 133:1125-1129 (Pubitemid 351829650)
63. Petzold A, Pittock S, Lennon V et al (2010) Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 81:109-111
64. Pittock SJ, Lennon VA (2008) Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 65:629-632 (Pubitemid 351679657)
65. Pittock SJ, Lennon VA, Seze J de et al (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:78-83
66. Pittock SJ, Lennon VA, Krecke K et al (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63:390-396
67. Pittock SJ, Weinshenker BG, Lucchinetti CF et al (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63:964-968 (Pubitemid 44036298)
68. Riphagen J, Modderman P, Verrips A (2010) Hiccups, nausea, and vomiting: water channels under attack! Lancet 375:954
69. Sellner J, Boggild M, Clanet M et al (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17:1019-1032
70. Shibasaki H, McDonald WI, Kuroiwa Y (1981) Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 49:253-271 (Pubitemid 11183868)
71. Shimizu J, Hatanaka Y, Hasegawa M et al (2010) IFN(beta)-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 75:1423-1427
72. Shimizu Y, Yokoyama K, Misu T et al (2008) Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 255:305-307
73. Takahashi T, Fujihara K, Nakashima I et al (2006) Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 210:307-313 (Pubitemid 44883971)
74. Takahashi T, Miyazawa I, Misu T et al (2008) Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry 79:1075-1078
75. Tanaka M, Tanaka K, Komori M (2009) Interferon-beta(1b) treatment in neuromyelitis optica. Eur Neurol 62:167-170
76. Wandinger KP, Stangel M, Witte T et al (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric SLE and primary Sjögren's syndrome. Arthritis Rheum 62:1198-1200
77. Watanabe S, Misu T, Miyazawa I et al (2007) Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler 13:968-974 (Pubitemid 351541430)
78. Watanabe S, Nakashima I, Misu T et al (2007) Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 13:128-132 (Pubitemid 46152772)
79. Waters P, Jarius S, Littleton E et al (2008) Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 65:913-919 (Pubitemid 352008474)
80. Weinshenker BG, O'Brien PC, Petterson TM et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878-886
81. Weinshenker BG, Wingerchuk DM, Vukusic S et al (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566-569 (Pubitemid 43358081)
82. Weinstock-Guttman B, Ramanathan M, Lincoff N et al (2006) Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 63:957-963 (Pubitemid 44036296)
83. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107-1114 (Pubitemid 29442132)
84. Wingerchuk DM, Lennon VA, Lucchinetti CF et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805-815 (Pubitemid 47238676)
85. Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485-1489 (Pubitemid 43958540)
86. Wingerchuk DM, Weinshenker BG (2008) Neuromyelitis optica. Curr Treat Options Neurol 10:55-66 (Pubitemid 351176056)